Bio-Techne (TECH) Misses Q4 EPS by 3c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Bio-Techne Corp. (TECH) PT Lowered to $500 at Stifel
August 4, 2022 3:52 PM EDTStifel analyst Daniel Arias lowered the price target on Bio-Techne Corp. (NASDAQ: TECH) to $500.00 (from $560.00) while maintaining a Buy rating following results.
The analyst commented, "TECH's finish to fiscal 2022 was solid, and marked by 14% organic that brought FY22 to 16%. Looking to FY23, mgmt's... More
